Federal regulators, legislators and policymakers in Washington are targeting national security, privacy, public health, and economic competitiveness risks from Chinese influence in the U.S. life sciences sector.
During this webinar, WilmerHale lawyers will explore how life sciences companies can navigate a wave of legislative and regulatory developments affecting foreign investment, government funding, export controls, sanctions, data protection, and trade policy.
*CLE credit is not available for those who watch a recording of the webinar.
